UK markets closed

Oramed Pharmaceuticals Inc (OJU1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.1570-0.0760 (-3.40%)
At close: 09:54PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
Total revenue
1,340
1,340
2,703
2,703
2,710
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
2,710
Operating expenses
Research development
8,971
8,971
27,639
20,989
10,235
Selling general and administrative
8,138
8,138
15,662
5,937
4,232
Total operating expenses
17,109
17,109
43,301
26,926
14,467
Operating income or loss
-15,769
-15,769
-40,598
-24,223
-11,757
Interest expense
2,037
2,037
0
-
-
Total other income/expenses net
16,268
16,268
-630
893
-438
Income before tax
5,088
5,088
-37,664
-22,989
-11,511
Income tax expense
0
0
100
-
0
Income from continuing operations
5,088
5,088
-37,764
-22,989
-11,511
Net income
5,525
5,525
-36,561
-22,238
-11,511
Net income available to common shareholders
5,525
5,525
-36,561
-22,238
-11,511
Basic EPS
-0.41
0.14
-0.94
-0.78
-0.56
Diluted EPS
-0.41
0.14
-0.94
-0.78
-0.56
Basic average shares
40,040
40,315
38,998
28,469
20,532
Diluted average shares
40,040
40,567
38,998
28,469
20,532